Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis: GPX7 regulates NF-kB

Carcinogenesis

Volumn 35, Issue 7, 2014, Pages

  Peng, Dun Fa ^a   Hu, Tian Ling ^a,c   Soutto, Mohammed ^a,c   Belkhiri, Abbes ^a   El Rifai, Wael ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Barrett's; Cancer; Cytokines; Glutathione peroxidase 7; Inflammation; NF B

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 7; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ONCOPROTEIN; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; GPX7 PROTEIN, HUMAN; MESSENGER RNA; PEROXIDASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; BARRETT CARCINOGENESIS; CARCINOGENESIS; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE ACTIVATION; GENE INDUCTION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE EXPRESSION; TRANSIENT EXPRESSION; TUMOR PROMOTION; WESTERN BLOTTING; ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL CULTURE; CELL TRANSFORMATION; DRUG ANTAGONISM; DRUG EFFECT; ESOPHAGUS TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; ESOPHAGEAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NF-KAPPA B; PEROXIDASES; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903983062     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu083     Document Type: Article

References (46)

1. Spechler, S.J. et al. (1986) Barrett's esophagus. N Engl J Med, 315, 362-371.
2. Shaheen, N.J. et al. (2009) Barrett's oesophagus. Lancet, 373, 850-861.
3. Gilbert, E.W. et al. (2011) Barrett's esophagus: a review of the literature. J Gastrointest Surg, 15, 708-718.
4. Zhang, H.Y. et al. (2009) Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett, 275, 170-177.
5. Abdel-Latif, M.M. et al. (2004) NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg, 239, 491-500.
6. Parkin, D.M. et al. (1999) Global cancer statistics. CA Cancer J Clin, 49, 33-64, 31.
7. O'Connor, J.B. et al. (1999) The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol, 94, 2037-2042.
8. Picardo, S.L. et al. (2012) Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer. Dig Surg, 29, 251-260.
9. Coussens, L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
10. Balkwill, F. et al. (2001) Inflammation and cancer: back to Virchow? Lancet, 357, 539-545.
11. Karin, M. (2006) Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-436.
12. Sehdev, V. et al. (2013) The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas. Cancer, 119, 904-914.
13. Soutto, M. et al. (2011) Loss of TFF1 is associated with activation of NF-kappaB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest, 121, 1753-1767.
14. Karin, M. (2006) NF-kappaB and cancer: mechanisms and targets. Mol Carcinog, 45, 355-361.
15. Barnes, P.J. et al. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med, 336, 1066-1071.
16. Huo, X. et al. (2011) Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-kappaB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol, 301, G278-286.
17. Debruyne, P.R. et al. (2006) Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology, 130, 1191-1206.
18. Naugler, W.E. et al. (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev, 18, 19-26.
19. Hacker, H. et al. (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE, 2006, re13.
20. Tselepis, C. et al. (2002) Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. Oncogene, 21, 6071-6081.
21. Mauro, C. et al. (2009) The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity. Methods Mol Biol, 512, 169-207.
22. Pyo, C.W. et al. (2008) Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB. Biochem Biophys Res Commun, 376, 180-185.
23. Brigelius-Flohe, R. et al. (2013) Glutathione peroxidases. Biochim Biophys Acta, 1830, 3289-3303.
24. Brigelius-Flohe, R. (1999) Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med, 27, 951-965.
25. Peng, D. et al. (2012) Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut, 61, 1250-1260.
26. Nguyen, V.D. et al. (2011) Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation. J Mol Biol, 406, 503-515.
27. Utomo, A. et al. (2004) Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. J Biol Chem, 279, 43522-43529.
28. Wei, P.C. et al. (2012) Loss of the oxidative stress sensor NPGPx compromises GRP78 chaperone activity and induces systemic disease. Mol Cell, 48, 747-759.
29. Peng, D. et al. (2013) Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma. Gut.
30. Peng, D.F. et al. (2009) DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut, 58, 5-15.
31. El-Rifai, W. et al. (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res, 62, 6823-6826.
32. Han, Y.H. et al. (2009) Tiron, a ROS scavenger, protects human lung cancer Calu-6 cells against antimycin A-induced cell death. Oncol Rep, 21, 253-261.
33. O'Riordan, J.M. et al. (2005) Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol, 100, 1257-1264.
34. Baron, J.A. et al. (2000) Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med, 51, 511-523.
35. Shaheen, N.J. (2010) Risk and reason in Barrett's esophagus. Clin Gastroenterol Hepatol, 8, 233-234.
36. Wang, F. et al. (2010) Nonsteroidal anti-inflammatory drugs and esophageal inflammation-Barrett's esophagus-adenocarcinoma sequence: a meta-analysis. Dis Esophagus.
37. Corley, D.A. et al. (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology, 124, 47-56.
38. Tak, P.P. et al. (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest, 107, 7-11.
39. Washburn, M.P. et al. (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol, 19, 242-247.
40. Cox, J. et al. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol, 26, 1367-1372.
41. Gales, D. et al. (2013) The Chemokine CXCL8 in Carcinogenesis and Drug Response. ISRN Oncol, 2013, 859154.
42. Sfikas, A. et al. (2012) The canonical NF-kappaB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage. Cell Signal, 24, 2007-2023.
43. Karin, M. (2008) The IkappaB kinase-a bridge between inflammation and cancer. Cell Res, 18, 334-342.
44. Oeckinghaus, A. et al. (2011) Crosstalk in NF-kappaB signaling pathways. Nat Immunol, 12, 695-708.
45. Bishop, G.A. et al. (2002) Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes. Journal of leukocyte biology, 72, 19-23.
46. Giai, C. et al. (2013) Shedding of Tumor Necrosis Factor Receptor 1 Induced by Protein A Decreases Tumor Necrosis Factor Alpha Availability and Inflammation during Systemic Staphylococcus aureus Infection. Infection and immunity, 81, 4200-4207.